These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 38673838)

  • 61. The CXCR4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis.
    Chen P; Zhang YL; Zhang XL; Guo Y; Tang PP
    Medicine (Baltimore); 2024 Apr; 103(14):e37681. PubMed ID: 38579048
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
    Ławicki S; Głażewska EK; Sobolewska M; Będkowska GE; Szmitkowski M
    Ann Lab Med; 2016 May; 36(3):223-9. PubMed ID: 26915610
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.
    Herszényi L; Hritz I; Lakatos G; Varga MZ; Tulassay Z
    Int J Mol Sci; 2012 Oct; 13(10):13240-63. PubMed ID: 23202950
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of C-reactive protein on the expression of matrix metalloproteinases and their inhibitors via Fcγ receptors on 3T3-L1 adipocytes.
    Nakai K; Tanaka H; Yamanaka K; Takahashi Y; Murakami F; Matsuike R; Sekino J; Tanabe N; Morita T; Yamazaki Y; Kawato T; Maeno M
    Int J Med Sci; 2017; 14(5):484-493. PubMed ID: 28539825
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis.
    Zheng TL; Cao K; Liang C; Zhang K; Guo HZ; Li DP; Zhao S
    Asian Pac J Cancer Prev; 2014; 15(19):8075-81. PubMed ID: 25338987
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer.
    Bumber B; Marjanovic Kavanagh M; Jakovcevic A; Sincic N; Prstacic R; Prgomet D
    Clin Otolaryngol; 2020 Jan; 45(1):55-62. PubMed ID: 31646745
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma.
    Meng YQ; Cao X; Wen ZS; Liu QW; Tan ZH; Duan H; Ma GW; Lin P
    Dis Esophagus; 2014; 27(7):670-7. PubMed ID: 24033446
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
    Cai M; Zheng Z; Bai Z; Ouyang K; Wu Q; Xu S; Huang L; Jiang Y; Wang L; Gao J; Pathak JL; Wu L
    BMC Cancer; 2022 May; 22(1):530. PubMed ID: 35545767
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients.
    Kozłowski M; Laudański W; Mroczko B; Szmitkowski M; Milewski R; Łapuć G
    Adv Med Sci; 2013; 58(2):227-34. PubMed ID: 23773968
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.
    Deans DA; Wigmore SJ; Gilmour H; Paterson-Brown S; Ross JA; Fearon KC
    Br J Cancer; 2006 Dec; 95(11):1568-75. PubMed ID: 17088911
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer.
    Łukaszewicz-Zając M; Kulczyńska-Przybik A; Muszyński P; Kozłowski M; Szmitkowski M; Mroczko B
    Pol Arch Med Wewn; 2016 Oct; 126(11):854-861. PubMed ID: 27906878
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
    Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
    Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
    Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
    BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer.
    Mohammed MA; Seleim MF; Abdalla MS; Sharada HM; Abdel Wahab AH
    BMC Urol; 2013 May; 13():25. PubMed ID: 23672427
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
    Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
    Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
    Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.